Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies

Tamara Shiner; Gitit Kavé; Anat Mirelman; Keren Regev; Yoav Piura; Orly Goldstein; Mali Gana Weisz; Anat Bar-Shira; Tanya Gurevich; Avi Orr-Urtreger; Roy N Alcalay; Nir Giladi; Noa Bregman

doi:10.1002/mds.30003

Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies

Tamara Shiner
, Gitit Kavé
, Anat Mirelman
, Keren Regev
, Yoav Piura
, Orly Goldstein
, Mali Gana Weisz
, Anat Bar-Shira
, Tanya Gurevich
, Avi Orr-Urtreger
, Roy N Alcalay
, Nir Giladi
, Noa Bregman

המחלקה לחינוך ולפסיכולוגיה

نتاج البحث: نشر في مجلة › مقالة › مراجعة النظراء

ملخص

BACKGROUND: Glucocerebrosidase 1 (GBA1) mutations are associated with reduced survival in Parkinson's disease but their effect on survival in dementia with Lewy bodies (DLB) is unclear.

OBJECTIVE: To assess the impact of GBA1 mutations on survival among Ashkenazi Jews with DLB, while controlling for APOE status.

METHODS: One hundred and forty participants from Tel Aviv Medical Center, Israel were genotyped for GBA1 mutations and APOE polymorphisms. Survival rates and follow-up cognitive screening scores were analyzed.

RESULTS: GBA1 mutation carriers had a two-fold increased risk of death (HR = 1.999), while APOE status did not independently affect survival. In a subset of patients with available clinical data (N = 63), carriers of the APOE ε4 allele showed faster cognitive deterioration, while GBA1 mutation carriers also declined more rapidly albeit not significantly.

CONCLUSION: Understanding the genetic effects on survival and progression is crucial for patient counseling and inclusion in clinical trials.

اللغة الأصلية	الإنجليزيّة
الصفحات (من إلى)	2280-2285
عدد الصفحات	6
دورية	Movement Disorders
مستوى الصوت	39
رقم الإصدار	12
تاريخ مبكر على الإنترنت	30 أغسطس 2024
المعرِّفات الرقمية للأشياء	https://doi.org/10.1002/mds.30003
حالة النشر	نُشِر - ديسمبر 2024

ملاحظة ببليوغرافية

الوصول إلى المستند

10.1002/mds.30003الترخيص: CC BY-NC-ND

الملفات والروابط الأخرى

Link to publication in Scopus

قم بذكر هذا

Shiner, T., Kavé, G., Mirelman, A., Regev, K., Piura, Y., Goldstein, O., Gana Weisz, M., Bar-Shira, A., Gurevich, T., Orr-Urtreger, A., Alcalay, R. N., Giladi, N., & Bregman, N. (2024). Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies. Movement Disorders, 39(12), 2280-2285. https://doi.org/10.1002/mds.30003

@article{b41bbac4269946df8b1d0935441dde61,

title = "Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies",

abstract = "BACKGROUND: Glucocerebrosidase 1 (GBA1) mutations are associated with reduced survival in Parkinson's disease but their effect on survival in dementia with Lewy bodies (DLB) is unclear.OBJECTIVE: To assess the impact of GBA1 mutations on survival among Ashkenazi Jews with DLB, while controlling for APOE status.METHODS: One hundred and forty participants from Tel Aviv Medical Center, Israel were genotyped for GBA1 mutations and APOE polymorphisms. Survival rates and follow-up cognitive screening scores were analyzed.RESULTS: GBA1 mutation carriers had a two-fold increased risk of death (HR = 1.999), while APOE status did not independently affect survival. In a subset of patients with available clinical data (N = 63), carriers of the APOE ε4 allele showed faster cognitive deterioration, while GBA1 mutation carriers also declined more rapidly albeit not significantly.CONCLUSION: Understanding the genetic effects on survival and progression is crucial for patient counseling and inclusion in clinical trials.",

keywords = "Aged, Aged, 80 and over, Apolipoproteins E/genetics, Disease Progression, Female, Genotype, Glucosylceramidase/genetics, Humans, Israel, Jews/genetics, Lewy Body Disease/genetics, Male, Middle Aged, Mutation/genetics, Polymorphism, Genetic/genetics",

author = "Tamara Shiner and Gitit Kav{\'e} and Anat Mirelman and Keren Regev and Yoav Piura and Orly Goldstein and \{Gana Weisz\}, Mali and Anat Bar-Shira and Tanya Gurevich and Avi Orr-Urtreger and Alcalay, \{Roy N\} and Nir Giladi and Noa Bregman",

note = "{\textcopyright} 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.",

year = "2024",

month = dec,

doi = "10.1002/mds.30003",

language = "אנגלית",

volume = "39",

pages = "2280--2285",

journal = "Movement Disorders",

issn = "0885-3185",

publisher = "John Wiley \& Sons Inc.",

number = "12",

}

Shiner, T, Kavé, G, Mirelman, A, Regev, K, Piura, Y, Goldstein, O, Gana Weisz, M, Bar-Shira, A, Gurevich, T, Orr-Urtreger, A, Alcalay, RN, Giladi, N & Bregman, N 2024, 'Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies', Movement Disorders, المجلد 39, رقم 12, الصفحات 2280-2285. https://doi.org/10.1002/mds.30003

TY - JOUR

T1 - Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies

AU - Shiner, Tamara

AU - Kavé, Gitit

AU - Mirelman, Anat

AU - Regev, Keren

AU - Piura, Yoav

AU - Goldstein, Orly

AU - Gana Weisz, Mali

AU - Bar-Shira, Anat

AU - Gurevich, Tanya

AU - Orr-Urtreger, Avi

AU - Alcalay, Roy N

AU - Giladi, Nir

AU - Bregman, Noa

PY - 2024/12

Y1 - 2024/12

N2 - BACKGROUND: Glucocerebrosidase 1 (GBA1) mutations are associated with reduced survival in Parkinson's disease but their effect on survival in dementia with Lewy bodies (DLB) is unclear.OBJECTIVE: To assess the impact of GBA1 mutations on survival among Ashkenazi Jews with DLB, while controlling for APOE status.METHODS: One hundred and forty participants from Tel Aviv Medical Center, Israel were genotyped for GBA1 mutations and APOE polymorphisms. Survival rates and follow-up cognitive screening scores were analyzed.RESULTS: GBA1 mutation carriers had a two-fold increased risk of death (HR = 1.999), while APOE status did not independently affect survival. In a subset of patients with available clinical data (N = 63), carriers of the APOE ε4 allele showed faster cognitive deterioration, while GBA1 mutation carriers also declined more rapidly albeit not significantly.CONCLUSION: Understanding the genetic effects on survival and progression is crucial for patient counseling and inclusion in clinical trials.

AB - BACKGROUND: Glucocerebrosidase 1 (GBA1) mutations are associated with reduced survival in Parkinson's disease but their effect on survival in dementia with Lewy bodies (DLB) is unclear.OBJECTIVE: To assess the impact of GBA1 mutations on survival among Ashkenazi Jews with DLB, while controlling for APOE status.METHODS: One hundred and forty participants from Tel Aviv Medical Center, Israel were genotyped for GBA1 mutations and APOE polymorphisms. Survival rates and follow-up cognitive screening scores were analyzed.RESULTS: GBA1 mutation carriers had a two-fold increased risk of death (HR = 1.999), while APOE status did not independently affect survival. In a subset of patients with available clinical data (N = 63), carriers of the APOE ε4 allele showed faster cognitive deterioration, while GBA1 mutation carriers also declined more rapidly albeit not significantly.CONCLUSION: Understanding the genetic effects on survival and progression is crucial for patient counseling and inclusion in clinical trials.

KW - Aged

KW - Aged, 80 and over

KW - Apolipoproteins E/genetics

KW - Disease Progression

KW - Female

KW - Genotype

KW - Glucosylceramidase/genetics

KW - Humans

KW - Israel

KW - Jews/genetics

KW - Lewy Body Disease/genetics

KW - Male

KW - Middle Aged

KW - Mutation/genetics

KW - Polymorphism, Genetic/genetics

UR - https://www.scopus.com/pages/publications/85202875545

U2 - 10.1002/mds.30003

DO - 10.1002/mds.30003

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 39212252

SN - 0885-3185

VL - 39

SP - 2280

EP - 2285

JO - Movement Disorders

JF - Movement Disorders

IS - 12

ER -

Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies

ملخص

ملاحظة ببليوغرافية

الوصول إلى المستند

الملفات والروابط الأخرى

بصمة

قم بذكر هذا